Skip to main content
RGS logo

RGS · Regis Corp · Executive Compensation

Track RGS — free
$27.50 +0.10 (+0.36%) At close · Sep 11
Market Cap
$68.47M
Shares
2.50M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Matthew Doctor $1,586,805
Kersten Zupfer $1,010,204
Jim B. Lain $946,495
Fiscal 2024
Executive Total
Matthew Doctor $1,842,007
John C. Davi $736,467
Kersten Zupfer $722,103
Fiscal 2023
Executive Total
Matthew Doctor $1,938,862
Kersten Zupfer $1,027,020
John C. Davi $961,878
Fiscal 2022
Executive Total
Matthew Doctor $1,943,921
Kersten Zupfer $1,287,855
Felipe A. Athayde $1,119,020
Jim B. Lain $900,138
Fiscal 2021
Executive Total
Felipe A. Athayde $10,494,979
Kersten Zupfer $986,216

Executive changes

Person Change Filed
William "Bill" Charters Appointed 2026-04-15
Andrew Alfano Appointed 2026-03-16
Susan Lintonsmith Appointed 2026-03-16
Jim Lain Appointed 2025-06-23
Matthew Doctor Resigned 2025-06-23
Matthew Doctor Resigned 2025-06-23
John Davi Terminated 2025-01-24
Susan Lintonsmith Appointed 2025-01-15
Michael Ferranti Appointed 2024-08-21
Jim Lain Appointed 2024-08-21
Key facts CIK 716643 CUSIP 758932206 13F (30d) 17 filings 17 filers Visit website Investor relations